基于影像表现与纹理分析预测新辅助治疗后胰腺导管腺癌可切除性及预后
研究纳入45例接受新辅助治疗后手术的胰腺导管腺癌患者,评估CT表现与纹理分析对可切除性和预后的预测价值。将临界可切除视为可切除对R0切除的准确率更高(68.9% vs 55.6%和51.1%,p<0.001),新辅助放化疗患者准确率优于化疗患者(p<0.001)。较高的减差值熵(截断值0.03,HR 0.159,p=0.005)和较低的减差值GLCM熵(截断值-0.35,HR 10.235,p=0.036)是预测更长总生存期的重要参数。
要点
- 将临界可切除判为可切除对R0切除准确率更高(68.9% vs 55.6%和51.1%,p<0.001)。
- 新辅助放化疗患者按此标准判读的可切除准确率优于化疗患者(p<0.001)。
- 减差值熵较高(截断值0.03)和减差值GLCM熵较低(截断值-0.35)提示预后较好。
核心结论
- CT表现结合纹理分析可能有助于预测胰腺导管腺癌新辅助治疗后的可切除性和预后。
研究设计与样本
- 研究纳入308例中的45例胰腺导管腺癌患者,均接受新辅助治疗(同步放化疗27例、化疗18例)后手术,术前均有基线和术前CT,由两名阅片者评估CT表现和可切除性,并以手术病理残余肿瘤为参考。
诊断标准与关键数值
- 将临界可切除视为可切除对R0切除的准确率为68.9%,将临界可切除视为不可切除的准确率为55.6%和51.1%,前者更高(p<0.001)。
- 新辅助放化疗患者按临界可切除视为可切除判读的准确率优于化疗患者(p<0.001)。
- 减差值熵截断值0.03,HR 0.159,p=0.005,预测更长总生存期。
- 减差值GLCM熵截断值-0.35,HR 10.235,p=0.036,预测更长总生存期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess utility of CT findings and texture analysis for predicting the resectability and prognosis in patients after neoadjuvant therapy for pancreatic ductal adenocarcinoma (PDAC).
MATERIALS AND METHODS: Among 308 patients, 45 with PDAC underwent neoadjuvant therapy (concurrent-chemoradiation-therapy, CCRT, n = 27 and chemotherapy, ChoT, n = 18) before surgery were included. All underwent baseline and preoperative CT. Two reviewers assessed CT findings and resectability. We analyzed relationship between CT resectability and residual tumor. CT texture values obtained by subtracting preoperative from baseline CT were analyzed using multivariate Cox/logistic regression analysis to identify significant parameters predicting resectability and prognosis.
RESULTS: There were 30 patients without residual tumor (CCRT, n = 20; ChoT, n = 10) and 15 with residual tumor (CCRT, n = 7; ChoT, n = 8). Considering borderline as resectable was more accurate for R0 resectability than considering borderline as unresectable (68.9% vs 55.6% and 51.1%, p < 0.001). Particularly, neoadjuvant CCRT provided better accuracy than that in (p < 0.001). In CT texture analysis, higher subtracted entropy (cut-off: 0.03, HR 0.159, p = 0.005) and lower subtracted GLCM entropy (cut-off: -0.35, HR 10.235, p = 0.036) are important parameters for prediction of longer overall survival.
CONCLUSION: CT findings with texture analysis can be useful for predicting a patient's outcome, including resectability and prognosis, after neoadjuvant therapy for PDAC.
KEY POINTS: • Considering borderline resectable tumor as resectable have better accuracy for resectability. • Considering borderline as resectable, CCRT-patients have better resectability accuracy than chemotherapy-patients. • Higher subtracted entropy and lower subtracted GLCM entropy are predictors of favorable outcome.
引用
- Kim BR, Kim JH, Ahn SJ, et al. CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis. Eur Radiol. 2018. PMID: 29931561. doi:10.1007/s00330-018-5574-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。